Logo image of BSAC

BANCO SANTANDER-CHILE-ADR (BSAC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BSAC - US05965X1090 - ADR

31.11 USD
-0.23 (-0.73%)
Last: 12/31/2025, 8:04:00 PM
31.11 USD
0 (0%)
After Hours: 12/31/2025, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BSAC. BSAC was compared to 388 industry peers in the Banks industry. BSAC has a medium profitability rating, but doesn't score so well on its financial health evaluation. BSAC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

Each year in the past 5 years BSAC has been profitable.
In multiple years BSAC reported negative operating cash flow during the last 5 years.
BSAC Yearly Net Income VS EBIT VS OCF VS FCFBSAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500B -500B 1T 1.5T

1.2 Ratios

BSAC's Return On Assets of 1.57% is amongst the best of the industry. BSAC outperforms 89.43% of its industry peers.
Looking at the Return On Equity, with a value of 23.39%, BSAC belongs to the top of the industry, outperforming 99.48% of the companies in the same industry.
Industry RankSector Rank
ROA 1.57%
ROE 23.39%
ROIC N/A
ROA(3y)1.05%
ROA(5y)1.06%
ROE(3y)16.98%
ROE(5y)17.65%
ROIC(3y)N/A
ROIC(5y)N/A
BSAC Yearly ROA, ROE, ROICBSAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of BSAC (31.11%) is better than 82.99% of its industry peers.
In the last couple of years the Profit Margin of BSAC has grown nicely.
The Operating Margin and Gross Margin are not available for BSAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 31.11%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-2.43%
PM growth 5Y3.1%
GM growth 3YN/A
GM growth 5YN/A
BSAC Yearly Profit, Operating, Gross MarginsBSAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, BSAC has about the same amount of shares outstanding.
BSAC has about the same amout of shares outstanding than it did 5 years ago.
BSAC has a better debt/assets ratio than last year.
BSAC Yearly Shares OutstandingBSAC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BSAC Yearly Total Debt VS Total AssetsBSAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20T 40T 60T

2.2 Solvency

BSAC has a debt to FCF ratio of 15.71. This is a negative value and a sign of low solvency as BSAC would need 15.71 years to pay back of all of its debts.
BSAC has a worse Debt to FCF ratio (15.71) than 81.44% of its industry peers.
A Debt/Equity ratio of 2.63 is on the high side and indicates that BSAC has dependencies on debt financing.
With a Debt to Equity ratio value of 2.63, BSAC is not doing good in the industry: 90.98% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.63
Debt/FCF 15.71
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
BSAC Yearly LT Debt VS Equity VS FCFBSAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5T 10T

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BSAC Yearly Current Assets VS Current LiabilitesBSAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2T 4T 6T 8T 10T

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.30% over the past year.
Measured over the past years, BSAC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.13% on average per year.
The Revenue has grown by 14.54% in the past year. This is quite good.
Measured over the past years, BSAC shows a small growth in Revenue. The Revenue has been growing by 5.93% on average per year.
EPS 1Y (TTM)40.3%
EPS 3Y3.53%
EPS 5Y9.13%
EPS Q2Q%1.56%
Revenue 1Y (TTM)14.54%
Revenue growth 3Y6.01%
Revenue growth 5Y5.93%
Sales Q2Q%2.46%

3.2 Future

Based on estimates for the next years, BSAC will show a small growth in Earnings Per Share. The EPS will grow by 6.04% on average per year.
BSAC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.52% yearly.
EPS Next Y23.01%
EPS Next 2Y14.04%
EPS Next 3Y11.8%
EPS Next 5Y6.04%
Revenue Next Year12.29%
Revenue Next 2Y9.13%
Revenue Next 3Y8.36%
Revenue Next 5Y5.52%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BSAC Yearly Revenue VS EstimatesBSAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1T 2T 3T
BSAC Yearly EPS VS EstimatesBSAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500 1K 1.5K 2K 2.5K

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
BSAC Price Earnings VS Forward Price EarningsBSAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BSAC Per share dataBSAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.04%
EPS Next 3Y11.8%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.52%, BSAC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.74, BSAC pays a better dividend. On top of this BSAC pays more dividend than 87.11% of the companies listed in the same industry.
BSAC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 4.52%

5.2 History

The dividend of BSAC decreases each year by -0.44%.
BSAC has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BSAC decreased recently.
Dividend Growth(5Y)-0.44%
Div Incr Years1
Div Non Decr Years1
BSAC Yearly Dividends per shareBSAC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

BSAC pays out 55.88% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP55.88%
EPS Next 2Y14.04%
EPS Next 3Y11.8%
BSAC Yearly Income VS Free CF VS DividendBSAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500B -500B 1T 1.5T
BSAC Dividend Payout.BSAC Dividend Payout, showing the Payout Ratio.BSAC Dividend Payout.PayoutRetained Earnings

BANCO SANTANDER-CHILE-ADR

NYSE:BSAC (12/31/2025, 8:04:00 PM)

After market: 31.11 0 (0%)

31.11

-0.23 (-0.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)01-29 2026-01-29/bmo
Inst Owners23.27%
Inst Owner Change4.36%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.66B
Revenue(TTM)3.45T
Net Income(TTM)1.07T
Analysts52
Price Target31.3 (0.61%)
Short Float %0.27%
Short Ratio1.39
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Yearly DividendN/A
Dividend Growth(5Y)-0.44%
DP55.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.28%
Min EPS beat(2)-5.4%
Max EPS beat(2)0.85%
EPS beat(4)3
Avg EPS beat(4)1.8%
Min EPS beat(4)-5.4%
Max EPS beat(4)9.65%
EPS beat(8)4
Avg EPS beat(8)-0.47%
EPS beat(12)5
Avg EPS beat(12)-7.2%
EPS beat(16)8
Avg EPS beat(16)-2.38%
Revenue beat(2)0
Avg Revenue beat(2)-2.06%
Min Revenue beat(2)-3.62%
Max Revenue beat(2)-0.49%
Revenue beat(4)1
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)0.11%
Revenue beat(8)3
Avg Revenue beat(8)-2.33%
Revenue beat(12)4
Avg Revenue beat(12)-1.48%
Revenue beat(16)8
Avg Revenue beat(16)3.17%
PT rev (1m)5.29%
PT rev (3m)16.08%
EPS NQ rev (1m)3.22%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.18%
Revenue NQ rev (1m)6.06%
Revenue NQ rev (3m)3.87%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.57%
ROE 23.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 31.11%
GM N/A
FCFM 33.18%
ROA(3y)1.05%
ROA(5y)1.06%
ROE(3y)16.98%
ROE(5y)17.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-2.43%
PM growth 5Y3.1%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 2.63
Debt/FCF 15.71
Debt/EBITDA N/A
Cap/Depr 69.11%
Cap/Sales 2.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 106.65%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)70.12%
Cap/Depr(5y)67.23%
Cap/Sales(3y)3.66%
Cap/Sales(5y)3.4%
Profit Quality(3y)98.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.3%
EPS 3Y3.53%
EPS 5Y9.13%
EPS Q2Q%1.56%
EPS Next Y23.01%
EPS Next 2Y14.04%
EPS Next 3Y11.8%
EPS Next 5Y6.04%
Revenue 1Y (TTM)14.54%
Revenue growth 3Y6.01%
Revenue growth 5Y5.93%
Sales Q2Q%2.46%
Revenue Next Year12.29%
Revenue Next 2Y9.13%
Revenue Next 3Y8.36%
Revenue Next 5Y5.52%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-49.86%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y180.56%
FCF growth 3YN/A
FCF growth 5Y-11.63%
OCF growth 1Y135%
OCF growth 3YN/A
OCF growth 5Y-10.82%

BANCO SANTANDER-CHILE-ADR / BSAC FAQ

What is the ChartMill fundamental rating of BANCO SANTANDER-CHILE-ADR (BSAC) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BSAC.


What is the valuation status for BSAC stock?

ChartMill assigns a valuation rating of 0 / 10 to BANCO SANTANDER-CHILE-ADR (BSAC). This can be considered as Overvalued.


How profitable is BANCO SANTANDER-CHILE-ADR (BSAC) stock?

BANCO SANTANDER-CHILE-ADR (BSAC) has a profitability rating of 4 / 10.


What is the financial health of BANCO SANTANDER-CHILE-ADR (BSAC) stock?

The financial health rating of BANCO SANTANDER-CHILE-ADR (BSAC) is 1 / 10.


What is the earnings growth outlook for BANCO SANTANDER-CHILE-ADR?

The Earnings per Share (EPS) of BANCO SANTANDER-CHILE-ADR (BSAC) is expected to grow by 23.01% in the next year.